Results 51 to 60 of about 52,371 (280)

Diagnostic Usefulness of Cell Block Samples in Fluid Overload‐Associated Large B‐Cell Lymphoma

Diagnostic Cytopathology, EarlyView.
ABSTRACT Fluid overload‐associated B‐cell lymphoma (FO‐LBCL) is a B‐cell neoplasm that presents as serous effusions without detectable tumor masses and Kaposi sarcoma‐associated herpesvirus (KSHV)/human herpesvirus 8 (HHV8) infection. Here, we report a case of an 81‐year‐old female patient with FO‐LBCL (Stage IVA) who presented with pericardial and ...
Hiroyuki Okanishi, Hiroko Kuwabara, Hiroko Nakayama, Mayo Odaka, Kozue Ariga, Isako Kataoka, Mari Tomiuka, Mayumi Uragami, Chihiro Deguchi, Shizuka Ono, Reika Takeda, Yoshitaka Kurisu, Yoshinobu Hirose, Yuuki Kinoshita, Taiji Yokote   +14 more
wiley   +1 more source

Does cancer cell-expressed SLAMF7 impact on CD47-mediated phagocytosis?

Molecular & Cellular Oncology, 2019
Innate immune checkpoint CD47 has emerged as a prominent target for cancer immunotherapy and defining biomarkers predictive of response will be a crucial step towards clinical implementation.
Renee Bouwstra, Tom van Meerten, Edwin Bremer   +2 more
doaj   +1 more source

Utility of reverse transcriptase – Multiplex ligation-dependant probe amplification (RT-MLPA) in the molecular classification of Diffuse Large B cell lymphoma (DLBCL) by cell-of-origin (COO)

Indian Journal of Pathology and Microbiology, 2023
Classifying diffuse large B cell lymphomas, not otherwise specified (DLBCL, NOS), is based on their cell-of-origin (COO) which is included in the WHO classification (2016), is essential to characterize them better in context of prognostication.
Nicholas Dcunha, Dhananjayan Sakhti, Elanthendral Sigamani, Jagan Chandramohan, Anu Korula, Biju George, Marie Therese Manipadam, Rekha Pai   +7 more
doaj   +1 more source

DLBCL of Waldeyer's ring_DATA_2019.6.24.sav

, 2019
DATA_Patients with early stage DLBCL of Waldeyer's ...
Ge Wen (6955388)
core   +1 more source

Next‐Generation CAR‐T Cell Therapy: From Modular Design to Clinical Expansion

Exploration, EarlyView.
Over the past decades, chimeric antigen receptor (CAR)‐T cell therapy has evolved from a linear engineering concept into a powerful yet constrained immunotherapy, limited by tumour microenvironment barriers, immune evasion, and manufacturing complexity.
Yuesong Bai, Jintao Qin, Zongjun Dai, Ran Yan, Yong Yang, Wenguang Wang   +5 more
wiley   +1 more source

An immunohistochemical study of diffuse large B-cell lymphoma with molecular subtyping based on Hans algorithm

Indian Journal of Pathology and Microbiology
Introduction: Diffuse large B-cell lymphoma (DLBCL) is the most common type of B-cell lymphoma accounting for about 40% of all lymphomas. The international prognostic index (IPI), which relies on clinical and laboratory parameters, is used as a ...
Anuradha Ananthamurthy, Megha Murali
doaj   +1 more source

NOTCH2 mutational status in three DLBCL cases.

, 2014
Abbreviation: NA, information not available; DLBCL, diffuse large B-cell lymphoma.NOTCH2 mutational status in three DLBCL cases.
Qingqing Wang (141110), Jing Zhao (21160), Ren Zhou (644036), Yuanyuan Weng (644032), Wei Zhang (405), Qian Lai (644033), Taobo Luo (644034), Qiang He (30485), Guoping Ren (112954), Yuehai Ke (198057), Yaoyao Shi (644031), Hongyang Pan (374320), Xinxia Zhang (644030), Wande Li (644035)   +13 more
core   +1 more source

High‐Grade B‐Cell Lymphoma With 11q Aberration in Africa: A Differential Diagnosis in Cases With Features of Endemic Burkitt Lymphoma

International Journal of Cancer, EarlyView.
ABSTRACT Fifty years ago, Zech et al. in this journal described for the first time the t(8;14) as a recurrent chromosomal aberration in Burkitt lymphoma (BL). Nevertheless, in regions where BL is not endemic, a subset of lymphomas with features of BL lacks the t(8;14)/IG::MYC and instead represents high‐grade B‐cell lymphoma with 11q aberration (HGBCL ...
Timothy Onyuma, Anja Fischer, Raffaella Guazzo, Mateus H. Gouveia, Noel Onyango, Cristiana Bellan, Susanne Bens, Roberto Boccacci, Michaela Feuring, Massimo Granai, Grace Kiraka, Alexandra G. Kouroukli, Stefano Lazzi, Cosimo Lori, Marianne Wanjiru Mureithi, Joshua Nyagol, Matthias Schlesner, Maria Chiara Siciliano, Margherita Vannucchi, Rabea Wagener, Nicholas Othieno‐Abinya, Sam M. Mbulaiteye, Lorenzo Leoncini, Reiner Siebert   +23 more
wiley   +1 more source

Central Nervous System Prophylaxis Utilization in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Within a Large Community Health System

Journal of Patient-Centered Research and Reviews
Purpose: The impact of central nervous system (CNS) prophylaxis in diffuse large B-cell lymphoma (DLBCL) is contentious. The CNS International Prognostic Index (IPI) calculator offers prognostic guidance in identifying those patients who may be at ...
Michael J. Williams, Sol D. Atienza, Renee H. Aranda, Kayleigh B. Flint, Sherjeel Sana, Stephen C. Medlin, Zartash Gul, Federico A. Sanchez, Michael A. Thompson   +8 more
doaj   +1 more source

Immunohistochemical analysis of EBI3 expression in classic BL and DLBCL.

, 2013
(A) Percentage of EBI3-positive tumoral cells in BL and DLBCL cases analyzed by EBI3 immunohistochemistry. (B) Frequency of EBI3-positive or -negative cases among BL and DLBCL, when positivity is defined by ≥30% stained tumoral cells. (C) Distribution of
Jean-Michel Picquenot (344706), Christian Bastard (344705), Isabelle Radford-Weiss (344707), Nicole Brousse (44590), Julie Gonin (344703), Jérôme Couturier (81165), Marie-Cécile Vacher-Lavenu (344709), Frédérique Larousserie (344704), Céline Dietrich (344708), Odile Devergne (344710)   +9 more
core   +1 more source